INBRIJA: payments to doctors
Payments that named INBRIJA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $6.9M
- Providers
- 7,413
- Transactions
- 37,520
- Average per transaction
- $184
The per-transaction average — $184 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,413 providers the average total is $932, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Acorda Therapeutics, Inc | $6,299,980 | 91.2% |
| Merz Pharmaceuticals, LLC | $606,102 | 8.8% |